<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-vaccines-07-00074">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gautam</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Nishimura</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Gaughan</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Gazumyan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Schoofs</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Buckler-White</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Seaman</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Swihart</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Follmann</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Nussenzweig</surname>
    <given-names>M.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection</article-title>
  <source>Nat. Med.</source>
  <year>2018</year>
  <volume>24</volume>
  <fpage>610</fpage>
  <lpage>616</lpage>
  <pub-id pub-id-type="doi">10.1038/s41591-018-0001-2</pub-id>
  <?supplied-pmid 29662199?>
  <pub-id pub-id-type="pmid">29662199</pub-id>
 </element-citation>
</ref>
